Press Releases on February 27, 2017 - EIN Presswire - Press Release Distribution Service

Published on February 27, 2017 - 13:00 GMT

Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy

PRINCETON, N.J., and HAMILTON, Bermuda, Feb. 27, 2017 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS) and SELLAS Life Sciences Group, both late-stage biopharmaceutical companies focused on developing cancer immunotherapies, today announced that Advaxis has …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 13:00 GMT

Study: More Brain Training is Better for Parkinson’s Patients

SAN FRANCISCO, Feb. 27, 2017 (GLOBE NEWSWIRE) -- A study published online (ahead of print) in the International Journal of Neuroscience indicates that “more is better,” when it comes to brain training for Parkinson’s patients. Researchers used computerized …

Distribution channels: IT Industry

Published on February 27, 2017 - 13:00 GMT

Fulgent Genetics to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference

TEMPLE CITY, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial Officer, are scheduled to participate in the 2017 BTIG Medical …

Distribution channels: Conferences & Trade Fairs, Technology

Published on February 27, 2017 - 13:00 GMT

Fate Therapeutics and Regents of the University of Minnesota Expand Research Collaboration for Clinical Translation of Engineered ...

Off-the-Shelf Natural Killer Cell Therapy Being Developed to Complement Standard-of-Care Monoclonal Antibody Treatment for Cancer First-of-Kind Product Candidate to be Manufactured from an Engineered Induced Pluripotent Stem Cell Line Intellectual Property …

Distribution channels: Retail

Published on February 27, 2017 - 13:00 GMT

Cellectar Biosciences Provides Phase I Trial Update of CLR 131 in Multiple Myeloma: Median Progression-Free Survival Extends to ...

MADISON, Wis., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today provides an update of its Phase I clinical study of CLR 131 in patients with relapsed or refractory …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 13:00 GMT

Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM) to Fund ...

SHANGHAI, China and CUPERTINO, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 13:00 GMT

AMAG and Palatin Announce Rekynda™ Data Presentations at the International Society for the Study of Women’s Sexual Health Annual ...

Both Phase 3 RECONNECT studies met co-primary endpoints and demonstrated significant improvement in key symptoms of hypoactive sexual desire disorder WALTHAM, Mass. and CRANBURY, N.J., Feb. 27, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 13:00 GMT

Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation

Immunomedics Intends to Implement a Non-Dilutive, Lower Risk and Potentially Higher Reward Strategy that Considers the Interests of ALL Stockholders Immunomedics’ Plan is Significantly Different from venBio’s Highly Risky and Expensive, Self-Interested …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology

Published on February 27, 2017 - 13:00 GMT

Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in the United Kingdom

National Institute for Health and Care Excellence (NICE) Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease CRANBURY, N.J., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology

Published on February 27, 2017 - 13:00 GMT

ChinaCache and PacketZoom Partner to Accelerate Mobile Apps in China

BEIJING, Feb. 27, 2017 (GLOBE NEWSWIRE) -- ChinaCache International Holdings Ltd. ("ChinaCache" or the "Company") (Nasdaq:CCIH), the leading total solutions provider of Internet content and application delivery services in China, today …

Distribution channels: Banking, Finance & Investment Industry, IT Industry

Published on February 27, 2017 - 12:59 GMT

ITG Launches Turnkey Research Payment Account Solution

NEW YORK and LONDON, Feb. 27, 2017 (GLOBE NEWSWIRE) -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, today announced the rollout of an enhanced Research Payment Account (RPA) solution to enable asset managers to adapt to …

Distribution channels: Banking, Finance & Investment Industry

Published on February 27, 2017 - 12:58 GMT

Europe Ship Searchlight Market 2017 Significant Growth,Technological Advancement & Opportunities to 2022

PUNE, INDIA, February 27, 2017 /EINPresswire.com/ -- WiseGuyReports.Com Publish a New Market Research Report On – “Europe Ship Searchlight Market 2017 Significant Growth,Technological Advancement & Opportunities to 2022”. A searchlight (or …

Distribution channels: Business & Economy, Electronics Industry ...

Published on February 27, 2017 - 12:43 GMT

Global NoSQL Market 2017 Share, Trend, Segmentation and Forecast to 2022

NoSQL -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2022 PUNE, MAHARASHTRA, INDIA, February 27, 2017 /EINPresswire.com/ -- NoSQL Industry Description Wiseguyreports.Com Adds “NoSQL -Market Demand, Growth, …

Distribution channels: Business & Economy, IT Industry ...

Published on February 27, 2017 - 12:39 GMT

Kirkland Lake Gold Beats 2016 Unit Cost Guidance; Provides 2017 Cost Outlook

TORONTO, ONTARIO--(Marketwired - Feb 27, 2017) - Kirkland Lake Gold Ltd. ("KL Gold" or the "Company") (TSX:KL)(OTCQX:KLGDF) is pleased to announce preliminary operating costs and All-In Sustaining Costs ('AISC') for the full …

Distribution channels: Mining Industry

Published on February 27, 2017 - 12:39 GMT

Turquoise Hill announces retirement of CFO

VANCOUVER, BC--(Marketwired - February 27, 2017) - Turquoise Hill Resources today announced the retirement of the Company's Chief Financial Officer Steeve Thibeault effective May 23, 2017. Turquoise Hill is in the process of initiating a search for Mr. …

Distribution channels: Mining Industry

Published on February 27, 2017 - 12:39 GMT

Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical

BOSTON, MA--(Marketwired - February 27, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform, today announced that it has granted …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 12:38 GMT

TC PipeLines, LP Announces 2016 Fourth Quarter and Year End Financial Results

HOUSTON, TEXAS--(Marketwired - Feb 27, 2017) - TC PipeLines, LP (NYSE:TCP) (the Partnership) today reported fourth quarter 2016 net income attributable to controlling interests of $60 million and distributable cash flow of $67 million. For the year ended …

Distribution channels: Energy Industry

Published on February 27, 2017 - 12:38 GMT

Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada

TORONTO, ON--(Marketwired - Feb 27, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 27, 2017 - 12:39 GMT

TransCanada Announces Offer to Sell 49.3% Interest in Iroquois and Remaining 11.8% Interest in PNGTS to TC PipeLines, LP

CALGARY, ALBERTA--(Marketwired - Feb 27, 2017) - TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) today announced it has offered to sell a 49.3 per cent interest in Iroquois Gas Transmission System, LP (Iroquois), together with its remaining 11.8 …

Distribution channels: Energy Industry

Published on February 27, 2017 - 12:39 GMT

Jourdan Announces Revocation of CTO, Reinstatement of Trading, Date of Annual Meeting and Shares for Debt Transactions

TORONTO, ONTARIO--(Marketwired - Feb 27, 2017) - JOURDAN RESOURCES INC. (TSX VENTURE:JOR) ("JOURDAN" or the "Company") (www.jourdan.ca) is pleased to report that the Ontario Securities Commission, as principal regulator, the British …

Distribution channels: Mining Industry